Public Comment

After the proposal is published in the Federal Register, the public has usually 30-90 days to respond to it. This deadline depends on the controversial nature of the notice and can be extended if a request to do so is made [anyone can request an extension]. All comments are sent to the Dockets Management Branch and then are forwarded to the Division of Over-the-Counter Drug Products. The comments are reviewed/evaluated by the appropriate team and, if needed, are sent to other discipline areas for further review.